Chukwuma Agu

CEO at ABS Biotechnologies GmbH

Speaker

Dr. Chukwuma Agu is an accomplished leader in stem cell biology and regenerative medicine with over 15 years of experience across academic, clinical, and biotech sectors. He previously served as Head of the Stem Cell Core Facility at the Institute of Molecular Biotechnology (IMBA) in Vienna and held senior scientific leadership roles at the Wellcome Trust Sanger Institute, where he led transformative programs in induced pluripotent stem cell (iPSC) technologies, translational research, and large-scale biomanufacturing.

Dr. Agu combines deep scientific expertise with strategic business acumen, holding an MBA in Healthcare from Coventry University, UK. As CEO of ABS Biotechnologies, he drives international collaborations and oversees the development of scalable, inclusive stem cell platforms that advance predictive drug testing and drug development. His work is at the forefront of creating human-relevant, ethically responsible solutions that accelerate scientific discovery and therapeutic innovation.